Borzan, V.; Lerchbaum, E.; Missbrenner, C.; Heijboer, A.C.; Goschnik, M.; Trummer, C.; Theiler-Schwetz, V.; Haudum, C.; Gumpold, R.; Schweighofer, N.;
et al. Risk of Insulin Resistance and Metabolic Syndrome in Women with Hyperandrogenemia: A Comparison between PCOS Phenotypes and Beyond. J. Clin. Med. 2021, 10, 829.
https://doi.org/10.3390/jcm10040829
AMA Style
Borzan V, Lerchbaum E, Missbrenner C, Heijboer AC, Goschnik M, Trummer C, Theiler-Schwetz V, Haudum C, Gumpold R, Schweighofer N,
et al. Risk of Insulin Resistance and Metabolic Syndrome in Women with Hyperandrogenemia: A Comparison between PCOS Phenotypes and Beyond. Journal of Clinical Medicine. 2021; 10(4):829.
https://doi.org/10.3390/jcm10040829
Chicago/Turabian Style
Borzan, Valentin, Elisabeth Lerchbaum, Cornelia Missbrenner, Annemieke C. Heijboer, Michaela Goschnik, Christian Trummer, Verena Theiler-Schwetz, Christoph Haudum, Roswitha Gumpold, Natascha Schweighofer,
and et al. 2021. "Risk of Insulin Resistance and Metabolic Syndrome in Women with Hyperandrogenemia: A Comparison between PCOS Phenotypes and Beyond" Journal of Clinical Medicine 10, no. 4: 829.
https://doi.org/10.3390/jcm10040829
APA Style
Borzan, V., Lerchbaum, E., Missbrenner, C., Heijboer, A. C., Goschnik, M., Trummer, C., Theiler-Schwetz, V., Haudum, C., Gumpold, R., Schweighofer, N., & Obermayer-Pietsch, B.
(2021). Risk of Insulin Resistance and Metabolic Syndrome in Women with Hyperandrogenemia: A Comparison between PCOS Phenotypes and Beyond. Journal of Clinical Medicine, 10(4), 829.
https://doi.org/10.3390/jcm10040829